Targeting cerebral arteriovenous malformations for minimally invasive therapy

Neurosurgery

Volumn 59, Issue 5 SUPPL., 2006, Pages

  Alexander, Michael J ^a   Tolbert, Marshall E ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Cerebral arteriovenous malformation; Embolization; Vascular endothelial growth factor; Vascular markers

Indexed keywords

BIOMATERIAL; CALCIUM ALGINATE; ENBUCRILATE; ETHYLENE VINYL ALCOHOL COPOLYMER; MICROSPHERE; RADIOSENSITIZING AGENT;

ARTIFICIAL EMBOLISM; BRAIN ARTERIOVENOUS MALFORMATION; HUMAN; MINIMALLY INVASIVE SURGERY; NONHUMAN; PRIORITY JOURNAL; RADIOSURGERY; RECANALIZATION; REVIEW; SILK; SUTURE;

EID: 33750373201     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000238530.44912.01     Document Type: Review

References (32)

1. Alexander MJ, DeSalles AA, Tomiyasu U: Multiple radiation-induced intracranial lesions after treatment for pituitary adenoma. J Neurosurg 88:111-115, 1998.
2. Becker TA, Preul MC, Bichard WD, Kipke DR, McDougall CG: Calcium alginate gel as a biocompatible material for endovascular arteriovenous malformation embolization: Six-month results in an animal model. Neurosurgery 56:793-801, 2005.
3. Becker TA, Tipke DR, Preul MC, Bichard WD, McDougall CG: In vivo assessment of calcium alginate gel for endovascular embolization of a cerebral arteriovenous malformation model using the Swine rete mirabile. Neurosurgery 51:453-458, 2002.
4. Bulsara KR, Alexander MJ, Villavicencio AT, Graffagnino C: De novo cerebral arteriovenous malformation: Case report. Neurosurgery 50:1137-1141, 2002.
5. Chang SD, Marcellus ML, Marks MP, Levy RP, Do HM, Steinberg GK: Multimodal treatment of giant intracranial arteriovenous malformations. Neurosurgery 53:1-11, 2003.
6. Chapman JD, Urtasun RC: The application in radiation therapy of substances which modify cellular radiation response. Cancer 40 [Suppl 1]:484-488, 1977.
7. Chen AY, Shih SJ, Garriques LN, Rothenberg ML, Hsiao M, Curran DP: Silatecan DB-67 is a novel DNA topoisomerase I-targeted radiation sensitizer. Mol Cancer Ther 4:317-324, 2005.
8. Do YS, Yakes WF, Shin SW, Lee BB, Kim DI, Liu WC, Shin BS, Kim DK, Choo SW, Choo IW: Ethanol embolization of arteriovenous malformations: Interim results. Radiology 235:674-682, 2005.
9. Duffner F, Ritz R, Bornemann A, Freudenstein D, Wiendl H, Siekmann R: Combined therapy of cerebral arteriovenous malformations: Histological differences between a nonadhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA). Clin Neuropathol 21:13-17, 2002.
10. Friedman WA, Bova FJ, Mendenhall WM: Linear accelerator radiosurgery for arteriovenous malformations: The relationship of size to outcome. J Neurosurg 82:180-189, 1995.
11. Hatva E, Jääskeläinen J, Hirvonen H, Alitalo K, Haltia M: Tie endothelial cell-specific receptor tyrosine kinase is upregulated in the vasculature of arteriovenous malformations. J Neuropathol Exp Neurol 55:1124-1133, 1996.
12. Jahan R, Murayama Y, Gobin YP, Duckwiler GR, Vinters HV, Viñuela F: Embolization of arteriovenous malformations with Onyx: Clinicopathological experience in 23 patients. Neurosurgery 48:984-995, 2001.
13. Jain RK: Antiangiogenic therapy for cancer: Current and emerging concepts. Oncology 19 [4 Suppl 3]:7-16, 2005.
14. Kilic T, Pamir MN, Kullu S, Eren F, Ozek NM, Black PM: Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 46:1179-1191, 2000.
15. Koizumi T, Shiraishi T, Hagihara N, Tabuchi K, Hayashi T, Kawano T: Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations. Neurosurgery 50:117-124, 2002.
16. Kvols LK: Radiation sensitizers: A selective review of molecules targeting DNA and non-DNA targets. J Nucl Med 46 [Suppl 1]:187S-190S, 2005.
17. Lee SW, Reece WD: Dose calculation of 142 Pr microspheres as a potential treatment for arteriovenous malformations. Phys Med Biol 50:151-166, 2005.
18. Luessenhop AJ, Presper JH: Surgical embolization of cerebral arteriovenous malformations through internal carotid and vertebral arteries: Long-term results. J Neurosurg 42:443-451, 1975.
19. Luessenhop AJ, Spence WJ: Artificial embolization of cerebral arteries: Report of use in a case of arteriovenous malformation. JAMA 172:1153-1155, 1960.
20. McCormick WF: Pathology of vascular malformations of the brain, in Wilson CB, Stein BM (eds): Intracranial Arteriovenous Malformations. Baltimore, Williams & Wilkins, 1984, pp 44-63.
21. Menezes da Silva FA, Newman EL: Time-dependent photodynamic damage to blood vessels: Correlation with serum photosensitizer levels. Photochem Photobiol 61:414-416, 1995.
22. Michelsen WJ: Natural history and pathophysiology of arteriovenous malformations. Clin Neurosurg 26:307-313, 1979.
23. n-BCA Trial Investigators: N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: Results of a prospective, randomized, multicenter trial. AJNR Am J Neuroradiol 23:748-755, 2002.
24. Rothbart D, Awad IA, Lee J, Kim J, Harbaugh R, Criscuolo GR: Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery 38:915-924, 1996.
25. Schlienger M, Atlan D, Lefkopoulos D, Merienne L, Touboul E, Missir O, Nataf F, Mammar H, Platoni K, Grandjean P, Foulquier JN, Huart J, Oppenheim C, Meder JF, Houdart E, Merland JJ: Linac radiosurgery for cerebral arteriovenous malformations: Results in 169 patients. Int J Radiat Oncol Biol Phys 46:1135-1142, 2000.
26. Schmidt-Erfurth U, Miller J, Sickenberg M, Bunse A, Laqua H, Gragoudas E, Zografos L, Birngruber R, van den Bergh H, Strong A, Manjuris U, Fsadni M, Lane AM, Piguet B, Bressler NM: Photodynamic therapy of subfoveal choroidal neovascularization: Clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol 236:365-374, 1998.
27. Song JK, Eskridge JM, Chung EC, Blake LC, Elliott JP, Finch L, Niakan C, Maravilla KR, Winn HR: Preoperative embolization of cerebral arteriovenous malformations with silk sutures: Analysis and clinical correlation of complications revealed on computerized tomography scanning. J Neurosurg 92:955-960, 2000.
28. Standard SC, Guterman LR, Chavis TD, Hopkins LN: Delayed recanalization of a cerebral arteriovenous malformation following angiographic obliteration with polyvinyl alcohol embolization. Surg Neurol 44:109-113, 1995.
29. Sure U, Butz N, Siegel AM, Mennel HD, Bien S, Bertalanffy H: Treatment-induced neoangiogenesis in cerebral arteriovenous malformations. Clin Neurol Neurosurg 103:29-32, 2001.
30. Valavanis A, Yaşargil MG: The endovascular treatment of brain arteriovenous malformations. Adv Tech Stand Neurosurg 24:131-214, 1998.
31. Yakes WF, Krauth L, Ecklund J, Swengle R, Dreisbach JN, Seibert CE, Baker R, Miller M, VanderArk D, Fullagar T, Prenger E: Ethanol endovascular management of brain arteriovenous malformations: Initial results. Neurosurgery 40:1145-1152, 1997.
32. Yamamoto Y, Coffey RJ, Nichols DA, Shaw EG: Interim report on the radiosurgical treatment of cerebral arteriovenous malformations. The influence of size, dose, time, and technical factors on obliteration rate. J Neurosurg 83:832-837, 1995.